Ignite Creation Date:
2024-05-06 @ 11:07 AM
Last Modification Date:
2024-10-26 @ 12:40 PM
Study NCT ID:
NCT03432364
Status:
COMPLETED
Last Update Posted:
2023-12-14
First Post:
2018-02-01
Brief Title:
A Study to Assess the Safety Tolerability and Efficacy of ST-400 for Treatment of Transfusion-Dependent Beta-thalassemia TDT
Sponsor:
Sangamo Therapeutics
Organization:
Sangamo Therapeutics
Organization Data
Organization:
Sangamo Therapeutics
Class:
INDUSTRY
Study ID:
ST-400-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Sangamo Therapeutics
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None